National Cancer Institute; Notice of Meeting, 52065-52066 [2017-24402]

Download as PDF sradovich on DSK3GMQ082PROD with NOTICES Federal Register / Vol. 82, No. 216 / Thursday, November 9, 2017 / Notices although the BSC will receive public comments only during the formal public comment periods, which are indicated on the preliminary agenda. Each organization is allowed one time slot per agenda topic. Each speaker is allotted at least 7 minutes, which if time permits, may be extended to 10 minutes at the discretion of the BSC chair. Persons wishing to present oral comments should register on the BSC meeting Web site by November 30, 2017, indicate whether they will present comments in-person or via the teleconference line, and indicate the topic(s) on which they plan to comment. The access number for the teleconference line will be provided to registrants by email prior to the meeting. On-site registration for oral comments will also be available on the meeting day, although time allowed for comments by these registrants may be limited and will be determined by the number of persons who register at the meeting. Persons registering to make oral comments are asked to send a copy of their statement and/or PowerPoint slides to the Designated Federal Officer by November 30, 2017. Written statements can supplement and may expand upon the oral presentation. If registering on-site and reading from written text, please bring 20 copies of the statement for distribution to the BSC and NTP staff and to supplement the record. Background Information on the BSC: The BSC is a technical advisory body comprised of scientists from the public and private sectors that provides primary scientific oversight to the NTP. Specifically, the BSC advises the NTP on matters of scientific program content, both present and future, and conducts periodic review of the program for the purpose of determining and advising on the scientific merit of its activities and their overall scientific quality. Its members are selected from recognized authorities knowledgeable in fields such as toxicology, pharmacology, pathology, biochemistry, epidemiology, risk assessment, carcinogenesis, mutagenesis, molecular biology, behavioral toxicology, neurotoxicology, immunotoxicology, reproductive toxicology or teratology, and biostatistics. Members serve overlapping terms of up to four years. The BSC usually meets biannually. The authority for the BSC is provided by 42 U.S.C. 217a, section 222 of the Public Health Service Act (PHS), as amended. The BSC is governed by the provisions of the Federal Advisory Committee Act, as amended (5 U.S.C. app.), which sets forth standards for the VerDate Sep<11>2014 17:32 Nov 08, 2017 Jkt 244001 formation and use of advisory committees. Dated: November 1, 2017. John R. Bucher, Associate Director, National Toxicology Program. [FR Doc. 2017–24401 Filed 11–8–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the joint meeting of the NCI Board of Scientific Advisors (BSA) and National Cancer Advisory Board (NCAB). The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting Web site (https:// videocast.nih.gov). A portion of the National Cancer Advisory Board meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended, for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Cancer Institute, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Advisory Board, Ad Hoc Subcommittee on Global Cancer Research. Open: November 28, 2017, 5:30 p.m. to 7:00 p.m. Agenda: Discussion on Global Cancer Research. Place: Gaithersburg Marriott Washingtonian Center, Lakeside Conference Room 1 and 2, 9751 Washington Boulevard, Gaithersburg, MD 20878. Contact Person: Dr. Edward Trimble, Executive Secretary, NCAB Ad Hoc Subcommittee on Global Cancer Research, National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, Room 3W562, Bethesda, MD 20892, (240) 276–5796, trimblet@ mail.nih.gov. PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 52065 Name of Committee: National Cancer Advisory Board, Ad Hoc Subcommittee on Population Science, Epidemiology and Disparities. Open: November 28, 2017, 7:30 p.m. to 9:00 p.m. Agenda: Discussion on Population Science, Epidemiology and Disparities. Place: Gaithersburg Marriott Washingtonian Center, Lakeside Conference Room 1 and 2, 9751 Washington Boulevard, Gaithersburg, MD 20878. Contact Person: Dr. Deborah Winn, Executive Secretary, NCAB Ad Hoc Subcommittee on Population Science, Epidemiology and Disparities, National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, Room 4E344, Bethesda, MD 20892, (240) 276–6755, winnde@mail.nih.gov. Name of Committee: NCI Board of Scientific Advisors and National Cancer Advisory Board. Open: November 29, 2017, 8:30 a.m. to 4:00 p.m. Agenda: Joint meeting of the NCI Board of Scientific Advisors and National Cancer Advisory Board; NCI Director’s report and presentations, NCI Board of Scientific Advisors Concepts Review. Closed: November 29, 2017, 4:30 p.m. to 5:30 p.m. Agenda: Review of intramural program site visit outcomes and the discussion of confidential personnel issues. Place: National Cancer Institute—Shady Grove, 9609 Medical Center Drive, Room TE406 & 408, Rockville, MD 20850. Contact Person: Paulette S. Gray, Ph.D., Director, Division of Extramural Activities, National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, Room 7W444, Bethesda, MD 20892, 240–276–6340, grayp@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NCI-Shady Grove campus. All visitors will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: NCAB: https:// deainfo.nci.nih.gov/advisory/ncab/ncab.htm, BSA: https://deainfo.nci.nih.gov/advisory/bsa/ bsa.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) E:\FR\FM\09NON1.SGM 09NON1 52066 Federal Register / Vol. 82, No. 216 / Thursday, November 9, 2017 / Notices Dated: November 6, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. Parkway, Suite 200, Durham, NC, USA 27713. Phone: (919) 293–1660, Fax: (919) 293–1645, Email: canden.byrd@ icf.com. [FR Doc. 2017–24402 Filed 11–8–17; 8:45 am] SUPPLEMENTARY INFORMATION: BILLING CODE 4140–01–P Background: The RoC is a congressionally mandated, sciencebased, public health report that identifies agents, substances, mixtures, or exposures (collectively called ‘‘substances’’) in our environment that pose a cancer hazard for people in the United States. NTP prepares the RoC on behalf of the Secretary of Health and Human Services. NTP follows an established, four-part process for preparing the RoC (https:// ntp.niehs.nih.gov/pubhealth/roc/ process/). For each substance selected for review, a draft RoC monograph is prepared that presents (1) information on human exposure to the substance; (2) an assessment of the evidence from cancer studies in humans and experimental animals, mechanisms of carcinogenicity, and other data relevant for evaluating the substance’s potential carcinogenicity; and (3) NTP’s preliminary RoC listing recommendation. The draft monograph also contains a draft profile that provides NTP’s preliminary listing recommendation for the substance and a summary of the scientific evidence considered key to reaching that recommendation. Antimony trioxide was selected for review following solicitation of public comment, review by the NTP Board of Scientific Counselors on December 14– 15, 2016, and approval by the NTP Director (https://ntp.niehs.nih.gov/go/ 9741). Antimony trioxide is the most commercially significant form of antimony and is a high-productionvolume chemical with a production volume exceeding one million pounds per year. Its major industrial use is as a synergist with halogenated flameretardants in textiles, plastics, and rubber. The main exposures to antimony trioxide are from inhalation of airborne solid dust and for workers in facilities producing or using antimony trioxide. Exposures of the public to antimony trioxide are primarily from environmental exposures secondary to human activities. Antimony trioxide can form in the product life cycle of other antimony compounds, such as during the use of automobile brake containing antimony trisulfate, which can oxidize into antimony trioxide. The draft RoC monograph includes a cancer hazard assessment of antimony trioxide. Meeting and Registration: The meeting is open to the public with time DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Draft Report on Carcinogens Monograph on Antimony Trioxide; Availability of Document; Request for Comments; Notice of Peer-Review Meeting AGENCY: National Institutes of Health, HHS. ACTION: Notice. The National Toxicology Program (NTP) announces a meeting to peer review the Draft Report on Carcinogens (RoC) Monograph on Antimony Trioxide. The Office of the Report on Carcinogens, Division of the National Toxicology Program (DNTP), National Institute of Environmental Health Sciences (NIEHS) prepared the monograph. This peer-review meeting is by webcast only and is open to the public. Registration is requested for oral comment and is required to access the webcast. Information about the meeting and registration is available at https:// ntp.niehs.nih.gov/go/38853. DATES: Meeting: January 24, 2018, 8:30 a.m. to adjournment at approximately 4:00 p.m. Eastern Standard Time (EST). The meeting may end sooner or later than 4:00 p.m. EST. Document Availability: The draft monograph should be available by November 30, 2017, at https:// ntp.niehs.nih.gov/go/38853. Written Public Comment Submissions: Deadline is January 10, 2018. Registration for Oral Comments: Deadline is January 10, 2018. Registration to View Webcast: Deadline is January 24, 2018. Registration to view the meeting webcast is required. ADDRESSES: Meeting Location: Webcast. Meeting Web page: The draft monograph, preliminary agenda, registration, and other meeting materials will be available at https:// ntp.niehs.nih.gov/go/38853. Webcast: The URL for viewing the peer-review meeting webcast will be provided to registrants. FOR FURTHER INFORMATION CONTACT: Canden Byrd, ICF, 2635 Meridian sradovich on DSK3GMQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:32 Nov 08, 2017 Jkt 244001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 set aside for oral public comment. Registration to view the webcast is by January 24, 2018, at https:// ntp.niehs.nih.gov/go/38853. Registration is required to view the webcast; the URL for the webcast will be provided in the email confirming registration. Individuals with disabilities who need accommodation to view the webcast should contact Canden Byrd by phone: (919) 293–1660 or email: canden.byrd@ icf.com. TTY users should contact the Federal TTY Relay Service at (800) 877– 8339. Requests should be made at least five business days in advance of the event. Meeting Materials: The draft monograph and preliminary agenda will be available on the NTP Web site at https://ntp.niehs.nih.gov/go/38853. The draft monograph should be available by November 30, 2017. Additional information will be posted when available or may be requested in hardcopy, contact Canden Byrd by phone: (919) 293–1660 or email: canden.byrd@icf.com. Following the meeting, a report of the peer review will be prepared and made available on the NTP Web site. Individuals are encouraged to access the meeting Web page to stay abreast of the most current information regarding the meeting. Request for Comments: NTP invites written and oral public comments on the draft monograph. The deadline for submission of written comments is January 10, 2018, to enable review by the peer-review panel and NTP staff prior to the meeting. Registration to provide oral comments is on or before January 10, 2018, at https:// ntp.niehs.nih.gov/go/38853. Written public comments and any other correspondence on the draft monograph should be sent to Canden Byrd by email: canden.byrd@icf.com. Persons submitting written comments should include name, affiliation, mailing address, phone, email, and sponsoring organization (if any). Written comments received in response to this notice will be posted on the NTP Web site, and the submitter will be identified by name, affiliation, and sponsoring organization (if any). Guidelines for public comments are available at https:// ntp.niehs.nih.gov/ntp/about_ntp/ guidelines_public_comments_508.pdf. Oral public comment at this meeting is welcome, with time set aside on January 24 for the presentation of oral remarks on the draft monograph. Public comments will be presented by teleconference line. Fifty (50) lines will be available for this call; availability is on a first-come, first-served basis. The lines will be open from 8:30 a.m. until E:\FR\FM\09NON1.SGM 09NON1

Agencies

[Federal Register Volume 82, Number 216 (Thursday, November 9, 2017)]
[Notices]
[Pages 52065-52066]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-24402]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the joint meeting of the NCI Board 
of Scientific Advisors (BSA) and National Cancer Advisory Board (NCAB).
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting. The open session will be 
videocast and can be accessed from the NIH Videocasting and Podcasting 
Web site (https://videocast.nih.gov).
    A portion of the National Cancer Advisory Board meeting will be 
closed to the public in accordance with the provisions set forth in 
section 552b(c)(6), Title 5 U.S.C., as amended, for the review, 
discussion, and evaluation of individual intramural programs and 
projects conducted by the National Cancer Institute, including 
consideration of personnel qualifications and performance, and the 
competence of individual investigators, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board, Ad Hoc 
Subcommittee on Global Cancer Research.
    Open: November 28, 2017, 5:30 p.m. to 7:00 p.m.
    Agenda: Discussion on Global Cancer Research.
    Place: Gaithersburg Marriott Washingtonian Center, Lakeside 
Conference Room 1 and 2, 9751 Washington Boulevard, Gaithersburg, MD 
20878.
    Contact Person: Dr. Edward Trimble, Executive Secretary, NCAB Ad 
Hoc Subcommittee on Global Cancer Research, National Cancer 
Institute--Shady Grove, National Institutes of Health, 9609 Medical 
Center Drive, Room 3W562, Bethesda, MD 20892, (240) 276-5796, 
trimblet@mail.nih.gov.

    Name of Committee: National Cancer Advisory Board, Ad Hoc 
Subcommittee on Population Science, Epidemiology and Disparities.
    Open: November 28, 2017, 7:30 p.m. to 9:00 p.m.
    Agenda: Discussion on Population Science, Epidemiology and 
Disparities.
    Place: Gaithersburg Marriott Washingtonian Center, Lakeside 
Conference Room 1 and 2, 9751 Washington Boulevard, Gaithersburg, MD 
20878.
    Contact Person: Dr. Deborah Winn, Executive Secretary, NCAB Ad 
Hoc Subcommittee on Population Science, Epidemiology and 
Disparities, National Cancer Institute--Shady Grove, National 
Institutes of Health, 9609 Medical Center Drive, Room 4E344, 
Bethesda, MD 20892, (240) 276-6755, winnde@mail.nih.gov.

    Name of Committee: NCI Board of Scientific Advisors and National 
Cancer Advisory Board.
    Open: November 29, 2017, 8:30 a.m. to 4:00 p.m.
    Agenda: Joint meeting of the NCI Board of Scientific Advisors 
and National Cancer Advisory Board; NCI Director's report and 
presentations, NCI Board of Scientific Advisors Concepts Review.
    Closed: November 29, 2017, 4:30 p.m. to 5:30 p.m.
    Agenda: Review of intramural program site visit outcomes and the 
discussion of confidential personnel issues.
    Place: National Cancer Institute--Shady Grove, 9609 Medical 
Center Drive, Room TE406 & 408, Rockville, MD 20850.
    Contact Person: Paulette S. Gray, Ph.D., Director, Division of 
Extramural Activities, National Cancer Institute--Shady Grove, 
National Institutes of Health, 9609 Medical Center Drive, Room 
7W444, Bethesda, MD 20892, 240-276-6340, grayp@mail.nih.gov.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NCI-Shady Grove campus. All 
visitors will be asked to show one form of identification (for 
example, a government-issued photo ID, driver's license, or 
passport) and to state the purpose of their visit.
    Information is also available on the Institute's/Center's home 
page: NCAB: https://deainfo.nci.nih.gov/advisory/ncab/ncab.htm, BSA: 
https://deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


[[Page 52066]]


    Dated: November 6, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-24402 Filed 11-8-17; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.